Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Drugs Used in the Treatment of HIV Infection

January 2008

Multi-Class Combination Products

Brand NameGeneric NamesManufacturer NameApproval DateTime to Approval
Atriplaefavirenz, emtricitabine and tenofovir disoproxil fumarateBristol-Myers Squibb and Gilead Sciences12-July-062.5 months


Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Brand NameGeneric Name(s)Manufacturer NameApproval DateTime to Approval
Combivirlamivudine and zidovudineGlaxoSmithKline27-Sep-973.9 months
Emtrivaemtricitabine, FTCGilead Sciences02-Jul-0310 months
Epivirlamivudine, 3TCGlaxoSmithKline17-Nov-954.4 months
Epzicomabacavir and lamivudineGlaxoSmithKline02-Aug-0410 months
Hividzalcitabine, dideoxycytidine, ddCHoffmann-La Roche19-Jun-927.6 months
Retrovirzidovudine, azidothymidine, AZT, ZDVGlaxoSmithKline19-Mar-873.5 months
Trizivirabacavir, zidovudine and lamivudineGlaxoSmithKline14-Nov-0010.9 months
Truvadatenofovir disoproxil fumarate and emtricitabineGilead Sciences, Inc.02-Aug-045 months
Videx ECenteric coated didanosine, ddI ECBristol Myers-Squibb31-Oct-009 months
Videxdidanosine, dideoxyinosine, ddIBristol Myers-Squibb9-Oct-916 months
Vireadtenofovir disoproxil fumarate, TDFGilead26-Oct-015.9 months
Zeritstavudine, d4TBristol Myers-Squibb24-Jun-945.9 months
Ziagenabacavir sulfate, ABCGlaxoSmithKline17-Dec-985.8 months


Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)

Brand NameGeneric NameManufacturer NameApproval DateTime to Approval
IntelenceetravirineTibotec Therapeutics18-Jan-086 months
Rescriptordelavirdine, DLVPfizer4-Apr-978.7 months
Sustivaefavirenz, EFVBristol Myers-Squibb17-Sep-983.2 months
Viramunenevirapine, NVPBoehringer Ingelheim21-Jun-963.9 months


Protease Inhibitors (PIs)

Brand NameGeneric Name(s)Manufacturer NameApproval DateTime to Approval
Ageneraseamprenavir, APVGlaxoSmithKline15-Apr-996 months
Aptivustipranavir, TPVBoehringer Ingelheim22-Jun-056 months
Crixivanindinavir, IDVMerck13-Mar-961.4 months
Fortovasesaquinavir (no longer marketed)Hoffmann-La Roche7-Nov-975.9 months
Invirasesaquinavir mesylate, SQVHoffmann-La Roche6-Dec-953.2 months
Kaletralopinavir and ritonavir, LPV/RTVAbbott Laboratories15-Sep-003.5 months
LexivaFosamprenavir Calcium, FOS-APVGlaxoSmithKline20-Oct-0310 months
Norvirritonavir, RTVAbbott Laboratories1-Mar-962.3 months
PrezistadarunavirTibotec, Inc.23-Jun-066 months
Reyatazatazanavir sulfate, ATVBristol-Myers Squibb20-Jun-036 months
Viraceptnelfinavir mesylate, NFVAgouron Pharmaceuticals14-Mar-972.6 months


Fusion Inhibitors

Brand NameGeneric NameManufacturer NameApproval DateTime to Approval
Fuzeonenfuvirtide, T-20Hoffmann-La Roche & Trimeris13-Mar-036 months


Entry Inhibitors -- CCR5 Co-Receptor Antagonist

Brand NameGeneric NameManufacturer NameApproval DateTime to Approval
SelzentrymaravirocPfizer06-August-078 months


HIV Integrase Strand Transfer Inhibitors

Brand NameGeneric NameManufacturer NameApproval DateTime to Approval
IsentressraltegravirMerck & Co., Inc.12-Oct-076 months


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by U.S. Food and Drug Administration. Visit the FDA's website to find out more about their activities and publications.
 
See Also
HIV Medications: When to Start and What to Take -- A Guide From TheBody.com
More on HIV Medications
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement